| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,883 |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 4,883 |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 2,426 | 2,927 | 3,726 | 3,607 | | Selling General and Administrative | 1,323 | 1,368 | 1,398 | 1,690 | | Non Recurring | 1,637 | 206 | 17 | 18 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (503) | (4,501) | (5,141) | (5,315) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17 | 11 | 27 | 73 | | Earnings Before Interest And Taxes | (486) | (4,490) | (5,114) | (5,242) | | Interest Expense | 109 | 105 | 104 | 105 | | Income Before Tax | (595) | (4,595) | (5,218) | (5,347) | | Income Tax Expense |
-
|
-
|
-
| (25) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (595) | (4,595) | (5,218) | (5,322) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (595) | (4,595) | (5,218) | (5,322) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($595) | ($4,595) | ($5,218) | ($5,322) |
|
0.50% Nasdaq 0.00%
Income Statement
